CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
50.17
-1.83 (-3.52%)
At close: Feb 4, 2026, 4:00 PM EST
50.16
-0.01 (-0.02%)
After-hours: Feb 4, 2026, 5:37 PM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.78 billion as of February 4, 2026. Its market cap has increased by 39.00% in one year.
Market Cap
4.78B
Enterprise Value
2.93B
1-Year Change
39.00%
Ranking
Category
Stock Price
$50.17
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.78B, an increase of 753.64%. That is a compound annual growth rate of 25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 4.89B | -2.15% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.29B |
| Protagonist Therapeutics | 5.19B |
| Celcuity | 5.15B |
| Crinetics Pharmaceuticals | 5.06B |
| Scholar Rock Holding | 4.75B |
| Apogee Therapeutics | 4.43B |
| ACADIA Pharmaceuticals | 4.42B |
| Amicus Therapeutics | 4.42B |